UGX 64,000
Sickle Cell Disease (SCD): It acts as a vital disease-modifying therapy. By stimulating the production of fetal hemoglobin (HbF), it prevents red blood cells from bending into abnormal sickle shapes. This significantly lowers the frequency of painful vaso-occlusive crises, acute chest syndrome, and the overall requirement for hospital admissions or blood transfusions.
Catalogue information is not medical advice. Prescription medicines and regulated supplies require appropriate documentation and verification before fulfilment.
| Classification | otc |
|---|
Sickle Cell Disease (SCD): It acts as a vital disease-modifying therapy. By stimulating the production of fetal hemoglobin (HbF), it prevents red blood cells from bending into abnormal sickle shapes. This significantly lowers the frequency of painful vaso-occlusive crises, acute chest syndrome, and the overall requirement for hospital admissions or blood transfusions.
